Akebia Therapeutics, Inc.
Pharmaceutical company · Cambridge, Massachusetts, United States · Nasdaq: AKBA
Akebia Therapeutics, Inc. is a pharmaceutical company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2007. Its shares trade on Nasdaq under the ticker AKBA. It has reported private securities offerings to the US SEC, most recently $14 million sold in a notice filed in 2011.
Akebia Therapeutics at a glance
What does Akebia Therapeutics do?
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $13.9 million sold (2011).
Frequently asked questions about Akebia Therapeutics
Where is Akebia Therapeutics headquartered?
Akebia Therapeutics, Inc. is headquartered in Cambridge, Massachusetts, United States.
What does Akebia Therapeutics do?
Akebia Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Akebia Therapeutics a public company?
Yes. Akebia Therapeutics, Inc. trades on Nasdaq under the ticker AKBA.
When was Akebia Therapeutics founded?
The earliest incorporation on record for Akebia Therapeutics, Inc. is in 2007, according to public company registers.
Similar companies
- Spero Therapeutics, Inc.Cambridge, Massachusetts, United States
- Sarepta Therapeutics, Inc.Cambridge, Massachusetts, United States
- Alnylam Pharmaceuticals, Inc.Cambridge, Massachusetts, United States
- Visterra, Inc.Cambridge, Massachusetts, United States
- Seres Therapeutics, Inc.Cambridge, Massachusetts, United States
- Merrimack Pharmaceuticals IncCambridge, Massachusetts, United States
- QurAlis CorpCambridge, Massachusetts, United States
- Apnimed, Inc.Cambridge, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.